Overview
BrainsWay develops Deep Transcranial Magnetic Stimulation (Deep TMS) devices using patented H-Coil technology to treat mental health conditions including major depressive disorder (MDD), OCD, anxious depression, late-life depression, and smoking addiction. Their noninvasive systems feature advanced stimulators with patient management capabilities and sham-enabled options for clinical research. FDA-cleared for MDD and OCD in the US, with CE marking for additional indications in Europe.
Frequently asked questions
- What regulatory clearances does BrainsWay Deep TMS have?
- FDA-cleared for major depressive disorder (MDD), OCD, anxious depression, late-life depression, and smoking addiction in the US; CE marked for additional psychiatric and neurological conditions in Europe.
- What are the key capabilities of BrainsWay Deep TMS systems?
- Noninvasive electromagnetic stimulation via patented H-Coils in a helmet to target deeper brain areas; includes stimulator with patient management, sham-enabled research modes, and 20-minute sessions without anesthesia.
- In which geographies is BrainsWay Deep TMS available?
- Available globally with FDA clearance in the US and CE marking in Europe; supports clinical operators worldwide through device provision and training.